IIPLA News
Saturday, May 2, 2026

US Maintains India on Special 301 Priority Watch List Citing Patent and Enforcement Concerns

Washington highlights ongoing challenges in India’s patent framework and intellectual property enforcement in latest trade report

IIPLA News Deskanonymous access0 articles left this week
US Maintains India on Special 301 Priority Watch List Citing Patent and Enforcement Concerns

The United States Trade Representative (USTR) has once again placed India on its Special 301 Priority Watch List, emphasizing ongoing concerns regarding India’s patent system and enforcement of intellectual property rights. This designation reflects persistent challenges that the U.S. government perceives in India’s IP regime, which have implications for bilateral trade and investment.

The Special 301 report, released annually by the USTR, identifies countries that do not provide adequate and effective protection of intellectual property rights or fair market access to U.S. persons relying on IP protection. India’s continued presence on the Priority Watch List signals that the U.S. remains concerned about certain aspects of India’s patent laws and the enforcement mechanisms in place.

Key issues highlighted include the complexities and perceived limitations within India’s patent framework, which some stakeholders argue hinder innovation and the protection of patented inventions. Additionally, enforcement gaps—such as delays in judicial processes and challenges in curbing infringement—are cited as areas requiring improvement.

This development comes amid a backdrop of evolving India-U.S. trade relations, where intellectual property protection remains a critical component. Previous discussions and negotiations have touched upon tariff policies, trade barriers, and market access, with IP enforcement consistently featuring as a priority for U.S. trade officials.

The USTR’s report also aligns with broader U.S. trade policy objectives, including addressing concerns over forced labor imports and recalibrating trade priorities in the South Asian region. India, as a major trading partner, remains under close observation for compliance with international IP standards.

Indian authorities have previously expressed commitment to strengthening IP protections while balancing public interest considerations. The government’s approach aims to foster innovation and investment while ensuring access to affordable medicines and technology.

The Special 301 listing serves as a diplomatic signal and a call for India to enhance its IP enforcement infrastructure, streamline patent examination and dispute resolution processes, and align its legal framework more closely with global norms.

As the U.S. continues to monitor India’s progress, stakeholders in both countries anticipate further dialogue and potential policy adjustments to address the highlighted concerns. The outcome of these efforts will be significant for the future trajectory of India-U.S. trade and intellectual property cooperation.

This latest report underscores the importance of robust IP regimes in facilitating international trade and protecting the interests of innovators and creators across borders. India’s response and reforms in this area will be closely watched by the global IP community and trade policymakers alike.

Share This Article
Ready-to-post copy includes the article link.

US Maintains India on Special 301 Priority Watch List Citing Patent and Enforcement Concerns The United States has retained India on its Special 301 Priority Watch List, underscoring persistent issues related to India’s patent regime and gaps in intellectual property enforcement. The annual report signals conti... Read the full IIPLA article: https://iipla.org/news/us-maintains-india-on-special-301-priority-watch-list-citing-patent-and-enforcement-concerns

Related Coverage

Continue in the newsroom

Back to newsroom
PatentsGlobal

Paul Weiss Expands Life Sciences Practice with Partner Ian Edvalson in San Francisco

Paul, Weiss, Rifkind, Wharton & Garrison has appointed Ian Edvalson as a partner in its San Francisco office, strengthening the firm’s life sciences transactions and intellectual property practices. Edvalson brings extensive experience advising biopharmaceutical and medical technology companies on licensing, collabora…

Friday, August 7, 2026
PatentsGlobal

Mexican Patent Law Overhaul Demands Early Strategic Planning from Applicants

In the first half of 2026, Mexico implemented sweeping patent reforms that significantly alter how patent applications are prepared, filed, and prosecuted. Key changes include a reduction in the number of substantive office actions and a mandated one-year examination timeline, compelling applicants to adopt earlier an…

Friday, August 7, 2026
PatentsGlobal

China Advances Comprehensive Pharmaceutical IP Protection with New Regulatory Frameworks

China’s pharmaceutical sector is rapidly evolving from generic manufacturing to innovative drug development, supported by a robust intellectual property protection system. Key measures including regulatory data protection, patent term extensions, patent linkage mechanisms, and strengthened judicial and administrative…

Friday, August 7, 2026
PatentsGlobal

T&G Global Posts Strong First-Half Results Driven by Premium Apple Sales

T&G Global reported a 2.6% revenue increase to $572.3 million for the six months ending June 30, 2024, led by a 6.1% rise in its Apples division revenue to $550.9 million. Operating profit grew 30% to $11.6 million before impairment adjustments related to the sale of T&G Fresh businesses. The company highlighted signi…

Friday, August 7, 2026